Study on antibody Fc-glycosylation for optimal effector functions.
Chem Commun (Camb)
; 59(37): 5555-5558, 2023 May 04.
Article
em En
| MEDLINE
| ID: mdl-37071468
ABSTRACT
A comprehensive structure-activity relationship study on antibody Fc-glycosylation has been performed using the chimeric anti-SSEA4 antibody chMC813-70 as a model. The α-2,6 sialylated biantennary complex type glycan was identified as the optimal Fc-glycan with significant enhancement in antibody effector functions, including binding to different Fc receptors and ADCC.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Imunoglobulina G
/
Fragmentos Fc das Imunoglobulinas
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article